INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

18,675 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$382K
1,240 sh
Jun 24, 2026Jun 26, 2026
Page 187 of 467
← PrevNext →
traded Jun 24, 2026
+2d
SEC Form 4

Evidence

14
VE
Venker EricPresident & Immunovant CEO
ROIVRoivant Sciences Ltd.
Open-market sale · 10b5-1 plan
SELL$5.08M
153.8K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

14
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$5.80M
78.9K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

14
SD
Seymour DavidEVP Chief Operating Officer
AALAmerican Airlines Group Inc.
Open-market sale · 10b5-1 plan
SELL$1.18M
69.3K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

14
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$5.27M
73.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

14
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.63M
35.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

14
SD
Seymour DavidEVP Chief Operating Officer
AALAmerican Airlines Group Inc.
Open-market sale · 10b5-1 plan
SELL$1.02M
56.5K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

14
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$7.93M
112.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$28K
5,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
1,696 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
504 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$70K
560 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

12
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$158K
504 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

12
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
683 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

12
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$1.28M
5,066 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

12
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.50M
61.7K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

12
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$5.57M
138.1K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

12
CL
Caldwell Jonathan L.Chief People Officer
VVVVALVOLINE INC
Open-market sale · 10b5-1 plan
SELL$114K
2,851 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

11
ST
Sakamoto Ryan T.EVP, Chief Legal Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$11K
2,978 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

11
IN
Islam NayaabSee Remarks
STUBStubHub Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$302K
25.1K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

11
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Open-market sale · 10b5-1 plan
SELL$296K
7,539 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

10
VE
Venker EricPresident & Immunovant CEO
ROIVRoivant Sciences Ltd.
Open-market sale · 10b5-1 plan
SELL$1.55M
46.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

10
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
228 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

10
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$1,521
12 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$302K
1,200 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

8
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
3,000 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

8
SJ
Simon Barry J.Director
IBRXImmunityBio, Inc.
Open-market sale · 10b5-1 plan
SELL$197K
25.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

8
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
320 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

8
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Open-market sale · 10b5-1 plan
SELL$102K
2,600 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

5
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
120 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

5
FM
Feld MichaelEVP, Chief Revenue Officer
BDXBECTON DICKINSON & CO
Open-market sale · 10b5-1 plan
SELL$11K
75 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

5
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$3,014
10 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

4
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
1,334 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

3
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$8,202
200 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
15.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$237K
15.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$237K
15.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

50
WL
Wang LaiPresident, Global Head of R&D
ONCBeOne Medicines Ltd.
Open-market sale
SELL$296K
1,068 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

47
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$357K
1,292 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

42
LA
Leggett Michael AdamSr VP & Chief Supply Chain Off
LZBLA-Z-BOY INC
Open-market sale
SELL$375K
9,000 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence